Toxicity and Antitumour Activity of Organotin Compounds in Mice
Author Information
Author(s): M. Gielen, R. Willem, H. Dalil, D. de Vos, C. M. Kuiper, G. J. Peters
Primary Institution: Free University of Brussels VUB
Hypothesis
The study investigates the in vivo toxicity and antitumour activity of various di- and triorganotin compounds in tumour-bearing mice.
Conclusion
Compounds 6 and 8 showed antitumour activity but also significant toxicity, making further evaluation challenging.
Supporting Evidence
- Compounds 6 and 8 showed clear antitumour activity after single dose administration.
- At their maximum tolerated doses, compounds 5, 7, 9, 10, and 11 showed no antitumour effect.
- Compounds 6 and 8 had promising results but were also highly toxic.
Takeaway
The researchers tested some chemicals on mice to see if they could help fight tumors, but they found that while some worked, they also made the mice very sick.
Methodology
Mice were injected with various organotin compounds, and their toxicity and antitumour effects were measured.
Limitations
The severe toxicity of the compounds complicates the interpretation of the antitumour results.
Participant Demographics
Balb/C mice were used in the study.
Want to read the original?
Access the complete publication on the publisher's website